Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment.
In a group of 25 post menopausal women mean age 57.2 years, treatment with Estriol vagina cream (Ovestin cream from Organon-Holland) gives rise (but within normal limits) to cholesterol, triglycerides and HDL-cholesterol, the protective factor against M. I. A rise in glycohemoglobin (HbA1C) statisticaly significant was noted, as a sign of slight glucose intolerance, but in no case was there a diabetic pattern. Vaginal Estriol cream was able to prevent osteoporosis. After a few weeks of treatment urinary calcium/creatinine ratio decreased. In the light of our own findings, Ovestin being a weak estrogen does not induce endometrial proliferation or breakthrough bleeding and does not modify the blood biochemistry, and can be recommended for postmenopausal syndrome even in familial hyperlipidemia diabetes, and for prevention of osteoporosis.
D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004964:Estriol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D014280:Triglycerides / Q000097:blood; D014622:Vaginal Creams, Foams, and Jellies
D002784:Cholesterol; D008076:Cholesterol, HDL; D003000:Clonidine; D004964:Estriol; D006442:Glycated Hemoglobin; D014280:Triglycerides; D014622:Vaginal Creams, Foams, and Jellies